Aptitude Medical Systems

We are excited to announce that Aptitude has been invited to give a talk at the 2025 Urgent Care Connect national conference organized by Experity! Aptitude is committed?to helping urgent care centers (UCCs) deliver better medicine and make better margins. We do so, not only with Metrix, our next-gen molecular testing platform, but also by directly helping UCCs develop better operational strategies based on the extensive insights we’ve accrued by studying how respiratory testing is practiced and reimbursed in UCCs nationwide. We are honored that Experity recognizes the value of our expertise in helping UCCs. Don't plan to attend but still curious about what we have to say? Please visit the dedicated Urgent Care page on our website (https://lnkd.in/gBzHpQYz) or listen to our webinar (https://lnkd.in/g4RKmJa6) to?learn more.

Exciting news! Aptitude’s Metrix? COVID/Flu test just received FDA Emergency Use Authorization! This game-changing molecular test: ? Detects SARS-CoV-2, Influenza A & B in just 20 minutes with PCR accuracy, ? Is authorized for over-the-counter and point-of-care use, ? Transforms the economics of molecular testing to increase access. Aptitude is revolutionizing infectious disease detection by making molecular diagnostics more accessible, faster, and cost-effective. This breakthrough empowers individuals and healthcare providers alike and is poised to disrupt how we approach respiratory health threats. See the press release here: https://lnkd.in/grNBcV33 #moleculardiagnostics #diagnostics #medtech #urgentcare #pointofcare

We are excited to announce that Aptitude has been awarded significant funding from the Bill & Melinda Gates Foundation to accelerate our game-changing STI testing solution for chlamydia, gonorrhea, and trichomoniasis. Building on the success of our FDA-authorized COVID-19 test, we're taking the next big leap in democratizing diagnostics by making STI testing affordable, easy, and available anywhere. Our mission is to bring high-quality molecular diagnostics to everyone, everywhere. The $10M+ funding will support clinical validation studies in the US and Africa, as well as manufacturing improvements, bringing us closer to making this vision a reality. #Diagnostics #STITesting #PointOfCare #GatesFoundation https://lnkd.in/gRzy2a38

We are excited to announce that Aptitude has been invited by the Urgent Care Association to give a talk at the 2025 Urgent Care Convention! Aptitude is committed?to enabling UCCs to deliver better medicine and make better margins. We do so, not only with Metrix, our next-gen molecular testing platform, but also by directly helping UCCs develop better operational strategies based on the extensive insights we’ve accrued by studying how respiratory testing is practiced and reimbursed in UCCs nationwide. We are honored that the UCA recognizes the value of our expertise in helping UCCs Evolve and Drive Changes. ? Can't wait until next May to hear what we have to say? Please join us at the NERUCA - North East Regional Urgent Care Association Webinar this Thursday, where we will share a sneak peek and some practical tips for this flu season! #UCA #NERUCA #UrgentCare

Aptitude is excited to sponsor the CalUCA annual conference in Irvine! Half of urgent care visits are for respiratory infectious diseases. Point-of-care molecular tests maximize clinical value and patient satisfaction by delivering definitive results to patients during the same visit. Unfortunately, traditional POC molecular tests are complicated, costly, and force providers into risky contracts - so they hurt your bottom line. Our Metrix? platform transforms molecular testing to provide the performance you'd expect without any of the downsides. Come visit our booth to learn how Metrix can help you unlock both better medicine and better margins!

Aptitude is attending the 1st SERUCA annual conference in Atlanta to introduce our breakthrough Metrix? molecular testing platform. We recently presented our platform and our value propositions to UCCs at the NERUCA annual conference with great reception. If you are a UCC operator looking to provide better medicine and improve your margins, please don’t hesitate to talk to our team at SERUCA to learn how we can help!

Aptitude is attending the 1st SERUCA annual conference in Atlanta to introduce our breakthrough Metrix? molecular testing platform. We recently presented our platform and our value propositions to UCCs at the NERUCA annual conference with great reception. If you are a UCC operator looking to provide better medicine and improve your margins, please don’t hesitate to talk to our team at SERUCA to learn how we can help!

Imagine a future where all common infectious diseases can be accurately diagnosed and treated without delay - how much anxiety and healthcare expense can be avoided? We developed the Metrix? molecular testing platform to provide the missing link for realizing that future. Metrix goes wherever accurate disease testing is needed, whether it’s in a pediatric office, an urgent care center, a pharmacy, or at home or office. We are exhibiting at HLTH (booth #5122) in Las Vegas next week - come talk to us to learn how Metrix can help improve infectious disease management in your organization! #HLTH

We developed the Metrix??molecular testing platform to empower distributed healthcare. Metrix helps every clinic provide rapid MDx on-site with no capital, no contract, and no training needed. It's a win-win for patients and clinics. We are on a whirlwind tour to introduce Metrix at the following meetings in the next two weeks: 1. NERUCA meeting in Connecticut #NERUCA #Urgentcare 2. AAFP FMX meeting in Pheonix?#AAFP #Familymedicine 3. AAP National Conference in Orlando #AAP #Pediatrics 4. Merchant Medicine Symposium in Nashville #Merchantmedicine #Urgentcare If you plan to?attend any of these meetings, please talk to us to learn how Metrix can help your practice provide better medicine with better margins!

Aptitude is excited to introduce our breakthrough Metrix? molecular testing platform at the Community Health Institute (CHI) & Expo in Atlanta. Community Health Centers (CHCs) are vital to health equity in America. Yet, CHCs face critical funding and staffing shortages that compromise their ability to deliver quality healthcare to over 30 million patients. Metrix empowers CHCs to improve health outcomes, patient experience, and operational efficiency. Metrix is the easiest-to-use MDx platform with no staff training or maintenance needed, and its disruptively simple design eliminates onerous cost structures. The upcoming Metrix Covid/Flu combo test (under FDA review) yields lab-accurate results: 3 diseases, 1 test, 20 minutes. Aptitude continues to democratize diagnostics so providers in CHCs and other distributed clinics can offer uncompromising care.